ICD Co. Ltd (040910) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ICD Co. Ltd (040910) has a cash flow conversion efficiency ratio of -0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.20 Billion ≈ $-2.85 Million USD) by net assets (₩98.48 Billion ≈ $66.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ICD Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
ICD Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how ICD Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ICD Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ICD Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Banxa Holdings Inc
V:BNXA
|
0.179x |
|
Bowler Metcalf Ltd
JSE:BCF
|
0.092x |
|
Highwood Asset Management Ltd
V:HAM
|
0.109x |
|
Carnival Industrial Corp
TW:1417
|
0.035x |
|
TransAct Technologies Incorporated
NASDAQ:TACT
|
-0.029x |
|
Instil Bio Inc.
NASDAQ:TIL
|
-0.012x |
|
S&S Power Switchgears Limited
NSE:S&SPOWER
|
-0.185x |
|
ICAPE HOLDING EO -40
F:Z8J
|
N/A |
Annual Cash Flow Conversion Efficiency for ICD Co. Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of ICD Co. Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see ICD Co. Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩98.48 Billion ≈ $66.74 Million |
₩8.01 Billion ≈ $5.43 Million |
0.081x | +128.35% |
| 2024-12-31 | ₩96.98 Billion ≈ $65.72 Million |
₩-27.81 Billion ≈ $-18.85 Million |
-0.287x | -2389.05% |
| 2023-12-31 | ₩127.18 Billion ≈ $86.19 Million |
₩-1.47 Billion ≈ $-993.12K |
-0.012x | +87.65% |
| 2022-12-31 | ₩153.25 Billion ≈ $103.85 Million |
₩-14.29 Billion ≈ $-9.69 Million |
-0.093x | -173.78% |
| 2021-12-31 | ₩167.94 Billion ≈ $113.81 Million |
₩21.23 Billion ≈ $14.39 Million |
0.126x | -54.19% |
| 2020-12-31 | ₩179.47 Billion ≈ $121.63 Million |
₩49.53 Billion ≈ $33.57 Million |
0.276x | +69.34% |
| 2019-12-31 | ₩147.06 Billion ≈ $99.66 Million |
₩23.97 Billion ≈ $16.24 Million |
0.163x | -28.22% |
| 2018-12-31 | ₩131.40 Billion ≈ $89.05 Million |
₩29.83 Billion ≈ $20.22 Million |
0.227x | +356.30% |
| 2017-12-31 | ₩134.14 Billion ≈ $90.91 Million |
₩-11.88 Billion ≈ $-8.05 Million |
-0.089x | -9.61% |
| 2016-12-31 | ₩112.69 Billion ≈ $76.37 Million |
₩-9.11 Billion ≈ $-6.17 Million |
-0.081x | -433.22% |
| 2015-12-31 | ₩90.88 Billion ≈ $61.59 Million |
₩2.20 Billion ≈ $1.49 Million |
0.024x | -92.01% |
| 2013-12-31 | ₩105.42 Billion ≈ $71.44 Million |
₩32.00 Billion ≈ $21.69 Million |
0.304x | -- |
About ICD Co. Ltd
ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, … Read more